Literature DB >> 22380484

ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.

Sichao Wang1, Youyong Li, Junmei Wang, Lei Chen, Liling Zhang, Huidong Yu, Tingjun Hou.   

Abstract

Inhibition of the human ether-a-go-go related gene (hERG) potassium channel may result in QT interval prolongation, which causes severe cardiac side effects and is a major problem in clinical studies of drug candidates. The development of in silico tools to filter out potential hERG potassium channel blockers in early stages of the drug discovery process is of considerable interest. Here, a diverse set of 806 compounds with hERG inhibition data was assembled, and the binary hERG classification models using naive Bayesian classification and recursive partitioning (RP) techniques were established and evaluated. The naive Bayesian classifier based on molecular properties and the ECFP_8 fingerprints yielded 84.8% accuracy for the training set using the leave-one-out (LOO) cross-validation procedure and 85% accuracy for the test set of 120 molecules. For the two additional test sets, the model achieved 89.4% accuracy for the WOMBAT-PK test set, and 86.1% accuracy for the PubChem test set. The naive Bayesian classifiers gave better predictions than the RP classifiers. Moreover, the Bayesian classifier, employing molecular fingerprints, highlights the important structural fragments favorable or unfavorable for hERG potassium channel blockage, which offers extra valuable information for the design of compounds avoiding undesirable hERG activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22380484      PMCID: PMC3324100          DOI: 10.1021/mp300023x

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  64 in total

Review 1.  ADMET in silico modelling: towards prediction paradise?

Authors:  Han van de Waterbeemd; Eric Gifford
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

2.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

Authors:  Y H Zhao; J Le; M H Abraham; A Hersey; P J Eddershaw; C N Luscombe; D Butina; G Beck; B Sherborne; I Cooper; J A Platts; D Boutina
Journal:  J Pharm Sci       Date:  2001-06       Impact factor: 3.534

3.  ADME evaluation in drug discovery. 2. Prediction of partition coefficient by atom-additive approach based on atom-weighted solvent accessible surface areas.

Authors:  T J Hou; X J Xu
Journal:  J Chem Inf Comput Sci       Date:  2003 May-Jun

4.  A model for identifying HERG K+ channel blockers.

Authors:  Alex M Aronov; Brian B Goldman
Journal:  Bioorg Med Chem       Date:  2004-05-01       Impact factor: 3.641

5.  Development and evaluation of an in silico model for hERG binding.

Authors:  Minghu Song; Matthew Clark
Journal:  J Chem Inf Model       Date:  2006 Jan-Feb       Impact factor: 4.956

6.  Inhibitory effect of carboxylic acid group on hERG binding.

Authors:  Bing-Yan Zhu; Zhaozhong J Jia; Penglie Zhang; Ting Su; Wenrong Huang; Erick Goldman; Daniel Tumas; Vic Kadambi; Priya Eddy; Uma Sinha; Robert M Scarborough; Yonghong Song
Journal:  Bioorg Med Chem Lett       Date:  2006-08-22       Impact factor: 2.823

Review 7.  The hERG potassium channel as a therapeutic target.

Authors:  Harry J Witchel
Journal:  Expert Opin Ther Targets       Date:  2007-03       Impact factor: 6.902

8.  Evaluation of zebrafish embryos as a model for assessing inhibition of hERG.

Authors:  S W Mittelstadt; C L Hemenway; M P Craig; J R Hove
Journal:  J Pharmacol Toxicol Methods       Date:  2007-12-23       Impact factor: 1.950

9.  Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.

Authors:  M L De Bruin; M Pettersson; R H B Meyboom; A W Hoes; H G M Leufkens
Journal:  Eur Heart J       Date:  2005-01-06       Impact factor: 29.983

Review 10.  hERG potassium channels and cardiac arrhythmia.

Authors:  Michael C Sanguinetti; Martin Tristani-Firouzi
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

View more
  34 in total

1.  Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.

Authors:  Hai-bo Yu; Bei-yan Zou; Xiao-liang Wang; Min Li
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 2.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

3.  Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds.

Authors:  Yanmin Zhang; Yu Jiao; Xiao Xiong; Haichun Liu; Ting Ran; Jinxing Xu; Shuai Lu; Anyang Xu; Jing Pan; Xin Qiao; Zhihao Shi; Tao Lu; Yadong Chen
Journal:  Mol Divers       Date:  2015-05-29       Impact factor: 2.943

4.  Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity.

Authors:  Chuipu Cai; Pengfei Guo; Yadi Zhou; Jingwei Zhou; Qi Wang; Fengxue Zhang; Jiansong Fang; Feixiong Cheng
Journal:  J Chem Inf Model       Date:  2019-02-15       Impact factor: 4.956

5.  Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.

Authors:  Li-li Liu; Jing Lu; Yin Lu; Ming-yue Zheng; Xiao-min Luo; Wei-liang Zhu; Hua-liang Jiang; Kai-xian Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

6.  In silico prediction of hERG potassium channel blockage by chemical category approaches.

Authors:  Chen Zhang; Yuan Zhou; Shikai Gu; Zengrui Wu; Wenjie Wu; Changming Liu; Kaidong Wang; Guixia Liu; Weihua Li; Philip W Lee; Yun Tang
Journal:  Toxicol Res (Camb)       Date:  2016-01-14       Impact factor: 3.524

7.  TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models.

Authors:  Zhi-Jiang Yao; Jie Dong; Yu-Jing Che; Min-Feng Zhu; Ming Wen; Ning-Ning Wang; Shan Wang; Ai-Ping Lu; Dong-Sheng Cao
Journal:  J Comput Aided Mol Des       Date:  2016-05-11       Impact factor: 3.686

Review 8.  The Next Era: Deep Learning in Pharmaceutical Research.

Authors:  Sean Ekins
Journal:  Pharm Res       Date:  2016-09-06       Impact factor: 4.200

9.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

Review 10.  Getting the most out of PubChem for virtual screening.

Authors:  Sunghwan Kim
Journal:  Expert Opin Drug Discov       Date:  2016-08-05       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.